Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
108: An all-star panel discuss EIS & VCTs in 2024 and look forward to 2025
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Update
Our research can be accessed for free under MIFID.
Find out more >
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Primary Health Properties
Investment Companies
Growing the footprint; optimising income and NAV
By
Mike Foster
29 Oct 2018
Allergy Therapeutics plc
Life Sciences
2018 full-year results: solid growth
By
Dr Martin Hall
27 Sep 2018
Stay up-to-date with the latest research
Sign up to our newsletter
Oxford BioMedica
Life Sciences
Partnering strategy delivering profitability
20 Sep 2018
City of London Investment Group
Financials
Strengthening cash position to boost returns
By
Dr Brian Moretta
20 Sep 2018
DP Poland Plc
Consumer
Initiation: Fully proven model rolls out
By
Jason Streets
18 Sep 2018
Tissue Regenix
Life Sciences
Strategy delivering growth above expectations
By
Dr Martin Hall
14 Sep 2018
Redx Pharma
Life Sciences
Back to the clinic
06 Sep 2018
Avacta Group plc
Life Sciences
Capital increase for further development
By
Dr Martin Hall
05 Sep 2018
Bionomics Ltd
Life Sciences
FY’18 – focus on PTSD drug development
By
Dr Martin Hall
03 Sep 2018
Advanced Oncotherapy
Life Sciences
Treatment planning system agreement
By
Dr Martin Hall
29 Aug 2018
Tissue Regenix
Life Sciences
1H’18 preview: organic plus inorganic growth
By
Dr Martin Hall
02 Aug 2018
Prev
1
...
17
18
19
20
21
...
30
Next
